- Report
- April 2023
- 112 Pages
Global
From €4519EUR$4,750USD£3,870GBP
- Report
- January 2022
- 120 Pages
Global
From €4519EUR$4,750USD£3,870GBP
- Report
- September 2022
- 157 Pages
North America
From €1998EUR$2,100USD£1,711GBP
€2854EUR$3,000USD£2,444GBP
- Report
- September 2022
- 159 Pages
Middle East, Africa
From €1998EUR$2,100USD£1,711GBP
€2854EUR$3,000USD£2,444GBP
- Report
- September 2022
- 177 Pages
Asia Pacific
From €1998EUR$2,100USD£1,711GBP
€2854EUR$3,000USD£2,444GBP
- Report
- June 2022
- 240 Pages
Global
From €3030EUR$3,185USD£2,595GBP
€4329EUR$4,550USD£3,707GBP
- Report
- May 2023
- 121 Pages
Global
From €3500EUR$3,941USD£3,102GBP
- Report
- April 2024
- 132 Pages
Global
From €904EUR$950USD£774GBP
- Report
- November 2021
- 545 Pages
Global
From €3806EUR$4,000USD£3,259GBP
- Report
- November 2021
- 1165 Pages
Global
From €5709EUR$6,000USD£4,888GBP
- Book
- December 2019
- 200 Pages
The Gene Panel market is a subset of the genomics industry that focuses on the development and sale of gene panels. These panels are collections of genes that are used to identify genetic variants associated with a particular disease or condition. They are used in clinical diagnostics, research, and drug development.
Gene panels are typically composed of hundreds to thousands of genes, and can be used to detect a wide range of genetic variants. They are often used to identify genetic markers associated with specific diseases, such as cancer, neurological disorders, and cardiovascular diseases.
The Gene Panel market is highly competitive, with a number of companies offering different types of panels. Companies in the market include Illumina, Thermo Fisher Scientific, Agilent Technologies, and Qiagen. Show Less Read more
